Perspective Therapeutics, Inc. — Director's Dealing 2021

Jul 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2021-07-01

Reporting Person: Hunt Jonathan Robert (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-01	Stock Options (right to buy)	$0.79	A	320000	Acquired	2031-07-01	Common Stock (320000)	Direct

Footnotes

F1: 25% vested as of 7/1/2021, and the remaining 75% will vest over the next three (3) years, commencing on 7/1/2022, until fully vested.